CCNA2 and neoplasm: The proliferative activity was analysed by immunohistochemistry using antibodies against Ki67 and cyclin A. An important methodological aspect of this paper was the direct quantitative comparison performed between the Ki67 analysis and the cyclin A analysis in the same tumour areas.